Pathological fracture of the proximal femur as first manifestation of malignancy of parotid gland

2011 ◽  
Vol 22 (3) ◽  
pp. 288-291
Author(s):  
Kamal Bali ◽  
Vishal Kumar ◽  
Uttam Saini ◽  
Shreekant Bharti
2021 ◽  
Vol 14 (2) ◽  
pp. e237086
Author(s):  
Hany Elbardesy ◽  
Rehan Gul ◽  
Michael Bennett ◽  
Derek G Power

A 65-year-old female patient has a history of malignant triton tumour of the right upper lobe of the lung. She underwent right upper lobectomy and lymphadenectomy in May 2018. She presented in November 2019 with pathological fracture of the left proximal femur. It was not associated with neurofibromatosis. We decided to do an excisional biopsy of the mass and proximal femoral replacement followed by radiotherapy. Four months later, she presented with local recurrence. We organised a multidisciplinary team between the orthopaedic, histopathology and oncology teams. Then, we decided to treat her with chemotherapy. After 2 months of follow-up, she responded well to the chemotherapy with no further deterioration of her condition.


2016 ◽  
Vol 3 (2) ◽  
pp. 115-118
Author(s):  
Shridhar D K ◽  
◽  
Ravishankar J ◽  
Rajesh Sajjan Shetty ◽  
Vijay Tubaki

2009 ◽  
Vol 64 (11) ◽  
pp. 1132-1135 ◽  
Author(s):  
D.-H. Suh ◽  
J.-R. Yoon ◽  
K.-B. Kang ◽  
S.-B. Han ◽  
H.J. Kim ◽  
...  

ISRN Oncology ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
C. R. Chandrasekar ◽  
R. J. Grimer ◽  
S. R. Carter ◽  
R. M. Tillman ◽  
A. Abudu ◽  
...  

Seventeen patients underwent treatment for a pathological fracture of the proximal femur due to osteosarcoma. Their age range was from 9 to 84 (mean age 42) with nine patients under the age of 40 and eight above the age of 40. Twelve patients had a fracture at diagnosis and five developed a fracture after the diagnosis. Seven patients had metastatic disease at diagnosis. Five patients were referred after internal fixation of the fracture prior to diagnosis. Chemotherapy was used when appropriate and eight patients then underwent limb salvage surgery, six had an amputation, and three had palliative treatment. The estimated five-year survival was 14%. These results are significantly worse than expected, and it proved impossible to identify any group who fared well. The high incidence of metastases both at diagnosis and subsequently suggests this group of patients are at very high risk. Review of multicentre data may suggest an optimum treatment for this patient group.


Sign in / Sign up

Export Citation Format

Share Document